http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1941910-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fbe62228a2464f6c01c7f47dd575d8f3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_24b4aee11752e7c69e485a21d0282e12 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 |
| filingDate | 2006-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dfaa938beb8495a4ad6200d46224a5de http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d0d154aa2a9d611f7fed0281d079798 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9874b3d84a32c9c821c445c16be5fe33 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d6f241706e2403a43fd2bd71dbdc69fc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fe91da72b7c1bfa8d7a418f319337e70 |
| publicationDate | 2008-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-1941910-A1 |
| titleOfInvention | Pharmaceutical form for the treatment of patients with acute cases and exacerbations of rheumatoid arthritis and related acute disorders |
| abstract | The invention relates to the pharmaceutical industry in general and to the pharmaceutical industry involved in the production of different pharmaceutical formulations containing non-steroidal anti-inflammatories and muscle relaxants and having a central analgesic action. More specifically, the invention relates to novel pharmaceutical formulations containing: (a) non-steroidal anti-inflammatories, (b) muscle relaxants, (c) analgesics, (d) one or more anti-adherent agents, (e) one or more disintegrating agents, (f) one or more binding agents, (g) one or more lubricants, (h) one or more diluents, (i) one or more flavouring agents, (j) one or more surfactants, (k) one or more wetting agents, (1) one or more suspension agents, (m) one or more sweetening agents, (n) one or more flocculating agents, (o) one or more preservatives, (p) one or more antimicrobial agents, (q) one or more pH-buffering systems and (r) one or more solvents and/or excipients, (s) one or more toning agents, (t) one or more antioxidants, (u) one or more chelating agents and any other additive necessary for the formulation. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103405335-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111316788-A |
| priorityDate | 2005-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 427.